🇺🇸 FDA

Company profile · Sponsor

Chiesi

Chiesi Farmaceutici S.p.A.

E2896DC · NMPA pharma PARMA, CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Chiesi (E2896DC) is a pharma company. headquartered in PARMA, CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E2896DC
Exchange NMPA
Company type pharma
Headquarters PARMA, CN

Pipeline (2)

Search pipeline →

  1. CHF 5993 100/6/12.5 µg

    Chiesi

    COPD (Chronic Obstructive Pulmonary Disease)

    phase 3 small molecule completed

    1 trial

  2. Experimental: CHF6001 3200 μg

    Chiesi

    Uncontrolled Asthma

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

What is Chiesi?

Chiesi (E2896DC) is a pharma company. headquartered in PARMA, CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Chiesi sponsor?

We track 2 ClinicalTrials.gov-linked programs for Chiesi, including CHF 5993 100/6/12.5 µg and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Chiesi company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.